Personalized Need-focused Single Session Intervention
Randomized Controlled Trial for Personalized Need-focused Single-Session Interventions
1 other identifier
interventional
240
2 countries
2
Brief Summary
This is a two-site randomized controlled trial, with two goals. First, the investigators aim to demonstrate that single-session interventions for mild-to-moderate anxiety and depression can generate statistically significant symptom change as a main effect across control and experimental (i.e. personalized) conditions. Second, the investigators hope to establish the additional incremental efficacy of personalization via person-specific intensive longitudinal data collection and analysis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jan 2023
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 8, 2023
CompletedFirst Submitted
Initial submission to the registry
March 18, 2023
CompletedFirst Posted
Study publicly available on registry
July 20, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedJuly 20, 2023
July 1, 2023
1.6 years
March 18, 2023
July 18, 2023
Conditions
Outcome Measures
Primary Outcomes (3)
Hamilton-Depression Rating Scale
(Range 0-52, higher scores denote greater depression)
Change between pre-intervention and 1 month post-intervention
Montgomery-Asberg Depression Rating Scale
(Range 0-60, higher scores denote greater depression)
Change between pre-intervention and 1 month post-intervention
Hamilton-Anxiety Rating Scale
(Range 0-56, higher scores denote greater anxiety); will be used in lieu of Hamilton-Depression ratings for individuals whose Hamilton-Anxiety scores are higher than their Hamilton-Depression scores.
Change between pre-intervention and 1 month post-intervention
Secondary Outcomes (3)
PHQ-8
Immediately prior to intervention, and again at 1 and 3 months post-intervention
GAD-7
Immediately prior to intervention, and again at 1 and 3 months post-intervention
DASS
Immediately prior to intervention, and again at 1 and 3 months post-intervention
Other Outcomes (5)
PANAS
Up to six weeks prior to intervention, and again at 1 and 3 months post-intervention
ERQ
Up to six weeks prior to intervention, and again at 1 and 3 months post-intervention
DERS-18
Up to six weeks prior to intervention, and again at 1 and 3 months post-intervention
- +2 more other outcomes
Study Arms (2)
Personalized Intervention
EXPERIMENTALThe intervention approach taken in this RCT is focused on unmet psychological needs (predictability, belonging, competence, self-worth, autonomy, and playfulness). For each need, a specific 90-minute intervention has been developed. The primary unmet need for each individual will be determined by a conditional entropy algorithm. Simply, the presence versus absence of subjective distress will be measured eight times per day for 30 days. Concurrently, the presence versus absence of need frustration will also be measured eight times per day for 30 days. Utilizing a k-fold cross-validated estimation, conditional entropy will be used to determine the need that best reduces the uncertainty in subjective distress (that is, best explains its presentation probabilistically). At both sites, the experimental condition will consist of an algorithmically-chosen intervention. The choice will be made based on data collected during thirty days of ecological momentary assessment.
Non-personalized Intervention
ACTIVE COMPARATORThe intervention approach taken in this RCT is focused on unmet psychological needs (predictability, belonging, competence, self-worth, autonomy, and playfulness). For each need, a specific 90-minute intervention has been developed. At the BIU site, the active control condition will consist of an intervention chosen randomly (out of the six mentioned above). At the UCB site, the active control condition will consist of a standard intervention addressing emotion regulation difficulties.
Interventions
All single-session interventions will be 90-minutes in length. At the conclusion of the intervention session, participants will receive suggestions for daily homework practice to complete and a flash drive with a copy of their session audio to review at their discretion. They will also meet with the therapist for a 10-minute remote check-in two weeks following the single session. All interventions include standard psychoeducational components. Both the standard intervention and the specific ones were designed to be broadly efficacious for depression and anxiety symptomatology. The psychosocial needs which serve as the focus of the interventions are derived from motivation and affect regulation models.
Eligibility Criteria
You may not qualify if:
- Psychotic Disorders (hallucinations or delusions)
- Past or current mania, current hypo-mania.
- Anorexia Disorder
- Current Obsessive-Compulsive and related Disorders rated as moderate and above.
- Alcohol or drug abuse rated as moderate and above.
- Panic Disorder rated as moderate and above.
- Agoraphobia rated as moderate and above.
- Premenstrual dysphoric disorder rated as moderate and above.
- Current Post-Traumatic Stress Disorder rated as moderate and above.
- binge eating rated as moderate and above.
- Phobia rated as severe and above.
- Somatic symptom disorder rated as severe and above.
- Illness Anxiety Disorder rated as severe and above.
- MDD rated as severe and above.
- GAD rated as severe and above.
- +2 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
University of California, Berkeley
Berkeley, California, 94720, United States
Bar-Ilan University
Ramat Gan, 52900, Israel
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The participants and any care provider and study personnel who interact with them will be blind to condition. The PI will utilize a randomization table to allocate participants to condition, and will inform the front-line study personnel and through them, the care provider, regarding which intervention to use without specifying whether it was personalized or randomly-chosen. The outcomes assessor will be blind even to the type of intervention utilized.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
March 18, 2023
First Posted
July 20, 2023
Study Start
January 8, 2023
Primary Completion
July 31, 2024
Study Completion
September 30, 2024
Last Updated
July 20, 2023
Record last verified: 2023-07